Related Experiment Video
Updated: Jul 8, 2026
07:10
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Octreotide for acute esophageal variceal bleeding: a meta-analysis
D A Corley1, J P Cello, W Adkisson
1Division of Gastroenterology, University of California, San Francisco 94143-0538, USA.
Gastroenterology
|March 7, 2001
Summary
Octreotide effectively controls esophageal variceal bleeding compared to other treatments. This meta-analysis shows octreotide is a safe and effective adjunctive therapy for variceal hemorrhage, though optimal use requires further study.
Area of Science:
- Gastroenterology
- Hepatology
- Clinical Pharmacology
Background:
- Esophageal variceal hemorrhage (EVH) poses significant risks.
- Previous studies on octreotide for EVH yielded inconsistent results.
- A comprehensive evaluation of octreotide's efficacy and safety is warranted.
Purpose of the Study:
- To statistically pool existing randomized trials on octreotide for EVH.
- To compare the efficacy and safety of octreotide against various control therapies.
- To determine octreotide's role as an adjunctive therapy in managing EVH.
Main Methods:
- Systematic identification of randomized trials from multiple sources.
- Blinded data abstraction by independent reviewers.
- Meta-analysis to synthesize efficacy and safety data.
Main Results:
- Octreotide significantly improved bleeding control compared to placebo and vasopressin/terlipressin.
- Efficacy was comparable to immediate sclerotherapy.
- Octreotide demonstrated fewer complications than vasopressin/terlipressin and a similar profile to placebo.
- No alternative therapy showed a mortality benefit.
Conclusions:
- Octreotide is favored over vasopressin/terlipressin for controlling esophageal variceal bleeding.
- Octreotide is a safe and effective adjunctive therapy post-variceal obliteration.
- Further research is needed to optimize octreotide dosage, route, and duration.
Related Concept Videos
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:26Esophageal Strictures-II: Clinical Features and Management
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
01:24Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...